Monthly dosing of 75 mg risedronate on 2 consecutive days a month: efficacy and safety resultsPierre D. Delmas, Michael R. McClung, Robert R. Recker et al.|Osteoporosis International|2007Cited by 68
A Novel Monthly Dosing Regimen of Risedronate for the Treatment of Postmenopausal Osteoporosis: 2-Year DataMichael R. McClung, Pierre D. Delmas, Claude-Laurent Benhamou et al.|Calcified Tissue International|2012Cited by 10
The Efficacy and Tolerability of a Monthly Dosing Regimen of 75mg Risedronate Dosed on 2 Consecutive Days a Month for the Treatment of Postmenopausal Women with Osteoporosis – 2 Year Study ResultsMichael R. McClung, Robert R. Recker, Claude Laurent Benhamou et al.|Journal of Clinical Densitometry|2009Cited by 0
A Novel Monthly Dosing Regimen of Risedronate for the Treatment of Postmenopausal Osteoporosis: 2-Year Data Michael R. McClungClaude-Laurent BenhamouZulema Man • Witold TlustochowiczJose R. ZanchettaRachelle EusebioAna M. Balske • Ellen MatzkinWojciech P. OlszynskiRobert ReckerPierre D. DelmasMichael R. McClung, José Zanchetta, Witold Tłustochowicz et al.|Unknown|2013Cited by 0